For example, our previous studies show that these two cell lines have different surface expression levels of drug efflux pumps (MDR1 and ABCG2), as well as different levels of cancer stem cell surface markers (EpCAM and CD133) [16]. This evidence concerns the gene ABCG2 and cancer.